Exhibit 107

Calculation of Filing Fee Table

Form F-1

(Form Type)

Clearmind Medicine Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type	Security Class Title	Fee Calculation Rule		Amount Registered(1)			Proposed Maximum Offering Price Per Share(4)			Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Equity	Common shares, no par value per share		457(c)		1,500,000	(2)	$	1.42	(3)	$	2,130,000.00	$	0.0001476	$	314.39
Total Offering Amount					1,500,000					$	2,130,000.00			$	314.39
Total Fees Previously Paid															—
Total Fee Offsets															—
Net Fee Due														$	314.39

(1)	Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Registrant is also registering hereunder an indeterminate number of additional shares of common stock that shall be issuable pursuant to Rule 416 to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2)	Consists of an aggregate of 1,500,000 of the Registrant’s common shares, no par value (the “Common Shares”) issuable upon the exercise of warrants. All 1,500,000 Common Shares are to be offered for resale by the selling shareholders named in the prospectus contained in this Registration Statement on Form F-1.
(3)	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act and based upon the average of the high and low sale prices of the Registrant’s Common Shares on the Nasdaq Capital Market on January 31, 2024.
(4)	The Registrant will not receive any proceeds from the sale of its Ordinary Shares by the selling shareholders.